Molecular Quality Control Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Analyte Type, By Application, By End-User, By Region & Competition, 2021-2031F

Description

The Global Molecular Quality Control Market is projected to expand from USD 0.34 Billion in 2025 to USD 0.51 Billion by 2031, registering a CAGR of 6.99%. Functioning as critical benchmarks, molecular quality controls employ synthetic or biological materials to validate nucleic acid testing precision and confirm the reliability of clinical diagnostics. This growth is primarily underpinned by strict adherence to laboratory accreditation norms, such as ISO 15189, which mandate regular proficiency testing, coupled with the increasing volume of infectious disease and genetic testing that necessitates verified control protocols.

Market Overview
Forecast Period	2027-2031
Market Size 2025	USD 0.34 Billion
Market Size 2031	USD 0.51 Billion
CAGR 2026-2031	6.99%
Fastest Growing Segment	Oncology Testing
Largest Market	North America

Despite these positive indicators, market penetration in developing areas faces significant hurdles due to the high expense of third-party controls and the logistical difficulties associated with cold-chain management. Operational data highlights the industry's adaptation to increasing testing complexity; for instance, the College of American Pathologists launched 18 new proficiency testing programs in 2024 to meet the shifting requirements of clinical laboratories.

Market Driver

Advancements in molecular diagnostic technologies, specifically the widespread adoption of Next-Generation Sequencing and multiplex assays, are a major force behind the demand for sophisticated quality control solutions. As laboratories implement high-throughput systems to examine complex genetic markers, there is an intensified need for multi-analyte controls capable of validating extensive genomic panels, ensuring accuracy in hereditary disease screening and oncology. This expansion of advanced genomic infrastructure is evidenced by Illumina's 'Form 10-K Fiscal Year 2023' report from February 2024, which noted the shipment of 352 NovaSeq X instruments, highlighting the broader footprint of high-complexity testing that requires rigorous quality assurance.

Simultaneously, the increasing prevalence of infectious diseases serves as a catalyst, demanding high-volume molecular testing and strict verification of diagnostic precision. The global focus on rapid pathogen detection has reoriented clinical workflows toward molecular techniques, which require ongoing proficiency testing to ensure regulatory compliance and patient safety. For example, the World Health Organization's 'Global Tuberculosis Report 2023', released in November 2023, indicated that molecular diagnostics usage reached a peak, with 47% of initial tuberculosis diagnoses utilizing a WHO-recommended rapid molecular test. Supporting the scale of these operations, Bio-Rad Laboratories reported in 2024 that its Clinical Diagnostics segment achieved approximately $1.53 billion in annual net sales, demonstrating the significant value placed on diagnostic assurance and testing support.

Market Challenge

The substantial cost of acquiring third-party molecular quality controls represents a major obstacle to market growth, especially in resource-limited settings. Clinical laboratories in emerging economies often face financial constraints, making it difficult to justify the purchase of premium, independent control materials amidst other operational needs. As a result, these facilities might decrease the frequency of quality control measures or resort to less stringent in-house options, which reduces revenue opportunities for commercial manufacturers and compromises the global standardization of diagnostic outcomes.

Additionally, the strict logistical demands for maintaining cold-chain integrity during storage and transport intensify these financial burdens. Molecular controls typically require preservation at sub-zero temperatures to remain stable, a requirement often difficult to meet in areas with inconsistent infrastructure. This logistical vulnerability results in product spoilage and increased waste, further discouraging adoption in decentralized locations. The consequences of such operational pressures are highlighted by recent industry trends; according to a 2024 survey by the Association for Diagnostics & Laboratory Medicine, 48% of laboratories intended to stop specific testing services due to the growing weight of compliance costs and resource limitations, thereby shrinking the potential market for molecular quality control products.

Market Trends

The market is being reshaped by the rising utilization of independent third-party quality controls, as clinical laboratories prioritize unbiased assessment tools over kit-included options to satisfy strict accreditation requirements. This transition is motivated by the necessity to reduce lot-to-lot variability and ensure consistent diagnostic accuracy across various reagent batches, which is essential for ISO 15189 compliance. Laboratories are actively adopting these independent materials to identify systematic errors that might be obscured by the optimized matrix compatibility of manufacturer-supplied controls, a demand reflected in Bio-Rad Laboratories' 'Third-Quarter 2024 Financial Results' from October 2024, where the Clinical Diagnostics segment reported $388.8 million in net sales driven largely by global demand for quality control products.

In parallel, the industry is undergoing a notable shift toward multiplexed and multi-analyte control panels aimed at enhancing workflow efficiency in high-volume testing settings. As diagnostic manufacturers combine multiple targets into single syndromic panels-especially for gastrointestinal and respiratory pathogens-laboratories need consolidated control materials capable of validating all targets at once, thereby cutting down on consumable costs and time associated with single-analyte controls. This consolidation bolsters the scalability of modern diagnostic centers, a trend supported by Revvity's 'Financial Results for the Third Quarter of 2024' in November 2024, which showed the Diagnostics segment generating $383 million in revenue, a 6% increase attributed to the continued adoption of specialized molecular and immunodiagnostic solutions.

Key Market Players

F. Hoffmann-La Roche Ltd.
Danaher Corporation
Bio-Rad Laboratories, Inc.
Anchor Molecular Inc.
Thermo Fisher Scientific, Inc.
Randox Laboratories Ltd.
Abbott Laboratories Inc.
Fortress Diagnostics Ltd
Ortho-Clinical Diagnostics, Inc.
Sun Diagnostics, LLC

Report Scope

In this report, the Global Molecular Quality Control Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Molecular Quality Control Market, By Product

Independent Controls
Instrument-Specific Controls

Molecular Quality Control Market, By Analyte Type

Single-Analyte Controls
Multi-Analyte Controls

Molecular Quality Control Market, By Application

Infectious Disease Diagnostics
Oncology Testing
Genetic Testing
Others

Molecular Quality Control Market, By End-User

Diagnostic Laboratories
Hospitals
IVD Manufacturers & Contract Research Organizations
Academic & Research Institutes
Others

Molecular Quality Control Market, By Region

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Molecular Quality Control Market.

Available Customizations:

Global Molecular Quality Control Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Molecular Quality Control Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Product (Independent Controls, Instrument-Specific Controls)
- 5.2.2. By Analyte Type (Single-Analyte Controls, Multi-Analyte Controls)
- 5.2.3. By Application (Infectious Disease Diagnostics, Oncology Testing, Genetic Testing, Others)
- 5.2.4. By End-User (Diagnostic Laboratories, Hospitals, IVD Manufacturers & Contract Research Organizations, Academic & Research Institutes, Others)
- 5.2.5. By Region
- 5.2.6. By Company (2025)
5.3. Market Map

6. North America Molecular Quality Control Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Product
- 6.2.2. By Analyte Type
- 6.2.3. By Application
- 6.2.4. By End-User
- 6.2.5. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Molecular Quality Control Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Product
    - 6.3.1.2.2. By Analyte Type
    - 6.3.1.2.3. By Application
    - 6.3.1.2.4. By End-User
- 6.3.2. Canada Molecular Quality Control Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Product
    - 6.3.2.2.2. By Analyte Type
    - 6.3.2.2.3. By Application
    - 6.3.2.2.4. By End-User
- 6.3.3. Mexico Molecular Quality Control Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Product
    - 6.3.3.2.2. By Analyte Type
    - 6.3.3.2.3. By Application
    - 6.3.3.2.4. By End-User

7. Europe Molecular Quality Control Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Product
- 7.2.2. By Analyte Type
- 7.2.3. By Application
- 7.2.4. By End-User
- 7.2.5. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Molecular Quality Control Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Product
    - 7.3.1.2.2. By Analyte Type
    - 7.3.1.2.3. By Application
    - 7.3.1.2.4. By End-User
- 7.3.2. France Molecular Quality Control Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Product
    - 7.3.2.2.2. By Analyte Type
    - 7.3.2.2.3. By Application
    - 7.3.2.2.4. By End-User
- 7.3.3. United Kingdom Molecular Quality Control Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Product
    - 7.3.3.2.2. By Analyte Type
    - 7.3.3.2.3. By Application
    - 7.3.3.2.4. By End-User
- 7.3.4. Italy Molecular Quality Control Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Product
    - 7.3.4.2.2. By Analyte Type
    - 7.3.4.2.3. By Application
    - 7.3.4.2.4. By End-User
- 7.3.5. Spain Molecular Quality Control Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Product
    - 7.3.5.2.2. By Analyte Type
    - 7.3.5.2.3. By Application
    - 7.3.5.2.4. By End-User

8. Asia Pacific Molecular Quality Control Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Product
- 8.2.2. By Analyte Type
- 8.2.3. By Application
- 8.2.4. By End-User
- 8.2.5. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Molecular Quality Control Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Product
    - 8.3.1.2.2. By Analyte Type
    - 8.3.1.2.3. By Application
    - 8.3.1.2.4. By End-User
- 8.3.2. India Molecular Quality Control Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Product
    - 8.3.2.2.2. By Analyte Type
    - 8.3.2.2.3. By Application
    - 8.3.2.2.4. By End-User
- 8.3.3. Japan Molecular Quality Control Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Product
    - 8.3.3.2.2. By Analyte Type
    - 8.3.3.2.3. By Application
    - 8.3.3.2.4. By End-User
- 8.3.4. South Korea Molecular Quality Control Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Product
    - 8.3.4.2.2. By Analyte Type
    - 8.3.4.2.3. By Application
    - 8.3.4.2.4. By End-User
- 8.3.5. Australia Molecular Quality Control Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Product
    - 8.3.5.2.2. By Analyte Type
    - 8.3.5.2.3. By Application
    - 8.3.5.2.4. By End-User

9. Middle East & Africa Molecular Quality Control Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By Analyte Type
- 9.2.3. By Application
- 9.2.4. By End-User
- 9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Molecular Quality Control Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Product
    - 9.3.1.2.2. By Analyte Type
    - 9.3.1.2.3. By Application
    - 9.3.1.2.4. By End-User
- 9.3.2. UAE Molecular Quality Control Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Product
    - 9.3.2.2.2. By Analyte Type
    - 9.3.2.2.3. By Application
    - 9.3.2.2.4. By End-User
- 9.3.3. South Africa Molecular Quality Control Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Product
    - 9.3.3.2.2. By Analyte Type
    - 9.3.3.2.3. By Application
    - 9.3.3.2.4. By End-User

10. South America Molecular Quality Control Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Product
- 10.2.2. By Analyte Type
- 10.2.3. By Application
- 10.2.4. By End-User
- 10.2.5. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Molecular Quality Control Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Product
    - 10.3.1.2.2. By Analyte Type
    - 10.3.1.2.3. By Application
    - 10.3.1.2.4. By End-User
- 10.3.2. Colombia Molecular Quality Control Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Product
    - 10.3.2.2.2. By Analyte Type
    - 10.3.2.2.3. By Application
    - 10.3.2.2.4. By End-User
- 10.3.3. Argentina Molecular Quality Control Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Product
    - 10.3.3.2.2. By Analyte Type
    - 10.3.3.2.3. By Application
    - 10.3.3.2.4. By End-User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Molecular Quality Control Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. F. Hoffmann-La Roche Ltd.
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Danaher Corporation
15.3. Bio-Rad Laboratories, Inc.
15.4. Anchor Molecular Inc.
15.5. Thermo Fisher Scientific, Inc.
15.6. Randox Laboratories Ltd.
15.7. Abbott Laboratories Inc.
15.8. Fortress Diagnostics Ltd
15.9. Ortho-Clinical Diagnostics, Inc.
15.10. Sun Diagnostics, LLC